<DOC>
	<DOCNO>NCT01978405</DOCNO>
	<brief_summary>Contrast-induced acute kidney injury ( CIAKI ) major complication adverse outcome contrast medium injection . Although risk develop CIAKI low patient normal renal function , dramatically high patient condition diabetes mellitus ( DM ) chronic kidney disease ( CKD ) . More recently , data show contrast agent induce endothelial dysfunction partially via free radical diabetes . Therefore , strategies prevent CIAKI endothelial dysfunction DM patient CKD urgently need . Alpha-lipoic acid reduce form , dihydrolipoate , potent antioxidant . We hypothesize alpha lipoic acid prevent contrast-induced acute kidney injury endothelial dysfunction type 2 diabetes .</brief_summary>
	<brief_title>Short-Term Alpha Lipoic Acid Therapy Prevention Contrast-induced Acute Kidney Injury Endothelial Dysfunction Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<mesh_term>Thioctic Acid</mesh_term>
	<criteria>type 2 diabetes nephropathy ( stage 3 4 ) recive alpha lipoic acid type 1 diabetes nephropathy ( stagte 1 , 2 5 ) hypersensitivity contrast medium IV heart failure lactic acidosis</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Nephropathy</keyword>
	<keyword>Contrast medium</keyword>
	<keyword>Alpha lipoic acid</keyword>
</DOC>